FDA staff push back on HHS peptide access plan


FDA staff push back on HHS peptide access plan

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.
FDA staff push back on HHS peptide access plan

A new policy is about drugs. Many FDA staff do not like it.

These drugs are called peptides. People use them to feel better.

The new policy says FDA will not stop sales. These drugs have no FDA safety check.

The Health Department made this plan. FDA staff had big safety worries about it.

Some peptides can be bad for health. The new plan adds safety rules for pharmacies.


Questions

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What is the new policy about?

It is about drugs, especially peptides.

Do FDA staff like the new policy?

No, many FDA staff do not like it and have safety worries.

Will the FDA stop the sales of these drugs?

No, the new policy says the FDA will not stop sales.


Describe the article image

Look at the article image and describe what you see on it. You may either speak or write your answer there.


Discussion

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com
All content and tasks are generated by AI inspired by a real publication.